Remove 2014 Remove Circulation Remove Risk Factors
article thumbnail

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation

Circulation, Ahead of Print. Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” have been updated with new evidence to guide clinicians.

article thumbnail

Abstract 4142629: Trends in Ischemic Heart Disease-Associated Mortality in Individuals with Diabetes Mellitus Type II

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4142629-A4142629, November 12, 2024. It also serves as an inviolable risk factor for diabetes mellitus type II-related mortality. Introduction:Over 9 million people are estimated to die annually due to Ischemic Heart Disease (IHD). Men had a higher AAMR than women, 11.57

article thumbnail

Prevalence of Systemic Hypertension and the Effects of Cerebral Revascularization in Patients With Moyamoya Disease

Stroke: Vascular and Interventional Neurology

We aimed to define the prevalence of systemic hypertension in MMD patients and characterize its evolution after cerebral revascularization.METHODSPatients with MMD treated with extracranial‐intracranial bypass from 2014 to 2018 were retrospectively enrolled. After a mean follow‐up of 34.3±18.1 months in adults (33.8±14.9

article thumbnail

"A patient just arrived as a transfer for NSTEMI."

Dr. Smith's ECG Blog

I quickly reviewed the patient’s records and saw that she was a 53 year old woman with a history of BMI 40, but no other identifiable risk factors for coronary artery disease. Circulation: Cardiovascular Interventions , 7(5), 645–655. "A patient just arrived as a transfer for NSTEMI." I performed bedside echocardiography.

SCAD 114
article thumbnail

How Apob & Visceral Fat Increase Your Risk Of Heart Disease.

Dr. Paddy Barrett

When it comes to cardiovascular disease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Visceral Fat & Insulin Resistance - The amount of fat in your abdominal cavity and major organs and how it influences your risk of insulin resistance.

article thumbnail

HDL dysfunction & It’s clinical Implication

Dr. S. Venkatesan MD

We are far away, from understanding the role and function of various molecules that get either activated or deactivated either in the circulation or inside the cells. Take care of all risk factors and lifestyles that is within your control. This is one of the reasons we find it to understand this molecule fully.

article thumbnail

Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD

Cardiometabolic Health Congress

Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1]

Obesity 52